LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Search

Penumbra Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

320.7 0.4

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

319.37

Max

321.56

Pagrindiniai rodikliai

By Trading Economics

Pajamos

163M

33M

Pardavimai

-11M

375M

P/E

Sektoriaus vid.

73.491

49.888

Pelnas, tenkantis vienai akcijai

0.82

Pelno marža

8.695

Darbuotojai

4,700

EBITDA

-30M

38M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+12.17% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-07-28

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-224M

13B

Ankstesnė atidarymo kaina

320.3

Ankstesnė uždarymo kaina

320.7

Naujienos nuotaikos

By Acuity

50%

50%

154 / 344 reitingas Healthcare

Penumbra Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-15 13:29; UTC

Įsigijimai, susijungimai, perėmimai

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- 2nd Update

2026-01-15 12:35; UTC

Įsigijimai, susijungimai, perėmimai

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- Update

2026-01-15 12:29; UTC

Įsigijimai, susijungimai, perėmimai

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

2026-05-06 20:15; UTC

Uždarbis

Penumbra Not Be Providing Fincl Guidance Due to Pending Acquisition by Boston Scientific >PEN

2026-05-06 20:07; UTC

Uždarbis

Penumbra 1Q Rev $374.8M >PEN

2026-05-06 20:07; UTC

Uždarbis

Penumbra 1Q EPS 82c >PEN

2026-02-25 18:02; UTC

Uždarbis

Penumbra: Won't Be Providing Financial Guidance for 2026, Citing Proposed Boston Scientific Deal

2026-02-25 18:01; UTC

Uždarbis

Penumbra 4Q Rev $385.4M >PEN

2026-02-25 18:01; UTC

Uždarbis

Penumbra 4Q Adj EPS $1.18 >PEN

2026-02-25 18:01; UTC

Uždarbis

Penumbra 4Q EPS $1.20 >PEN

2026-01-24 06:18; UTC

Įsigijimai, susijungimai, perėmimai

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

2026-01-15 14:37; UTC

Karštos akcijos

Stocks to Watch Thursday: Goldman Sachs, Boston Scientific, BlackRock -- WSJ

2026-01-15 13:45; UTC

Įsigijimai, susijungimai, perėmimai

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. -- Barrons.com

2026-01-15 12:04; UTC

Įsigijimai, susijungimai, perėmimai

Boston Scientific: Penumbra Shareholders Can Elect to Receive Cash or Stock >BSX PEN

2026-01-15 12:03; UTC

Įsigijimai, susijungimai, perėmimai

Boston Scientific: Acquisition to Expand Cardiovascular Portfolio >BSX PEN

2026-01-15 12:01; UTC

Įsigijimai, susijungimai, perėmimai

Boston Scientific: Penumbra Deal Carriers an Enterprise Value of About $14.5 Billion >BSX

2026-01-15 12:00; UTC

Įsigijimai, susijungimai, perėmimai

Boston Scientific to Buy Penumbra for $374/Share >BSX PEN

2026-01-15 12:00; UTC

Įsigijimai, susijungimai, perėmimai

Boston Scientific Announces Agreement To Acquire Penumbra, Inc. >BSX PEN

Akcijų palyginimas

Kainos pokytis

Penumbra Inc Prognozė

Kainos tikslas

By TipRanks

12.17% į viršų

12 mėnesių prognozė

Vidutinis 358.25 USD  12.17%

Aukščiausias 374 USD

Žemiausias 335 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Penumbra Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

4 ratings

1

Pirkti

3

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

154 / 344 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat